Parallel Advisors, LLC Cytokinetics Inc Transaction History
Parallel Advisors, LLC
- $4.34 Billion
- Q4 2024
A detailed history of Parallel Advisors, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 183 shares of CYTK stock, worth $7,903. This represents 0.0% of its overall portfolio holdings.
Number of Shares
183
Previous 412
55.58%
Holding current value
$7,903
Previous $21,000
61.9%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
114MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$634 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$515 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$464 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$266 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$123 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.07B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...